Tag: Biotechnology
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic,...
Novo Nordisk on Tuesday asked the Food and Drug Administration to prevent compounding pharmacies from making unapproved and often cheaper versions of its...
Drug costs, abortion, Obamacare: How Trump and Harris could change U.S....
President Donald Trump talks to the press outside the White House, July 19, 2019, left, and Democratic presidential nominee and U.S. Vice President...
Merck says experimental RSV treatment protected infants in trial, paving way...
The logo for Merck is displayed on a screen at the New York Stock Exchange on Nov. 17, 2021.Andrew Kelly | ReutersMerck on...
Novavax says FDA put hold on combination Covid-flu shot and influenza...
A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on...
Walgreens says it will close 1,200 stores by 2027, as earnings...
A sign sits in front of a Walgreens store on November 10, 2023 in Wheeling, Illinois. Scott Olson | Getty ImagesWalgreens on Tuesday reported...
CVS, UnitedHealth, Cigna say FTC should take Lina Khan and two...
FTC Chairwoman Lina Khan testifies during the House Appropriations Subcommittee on Financial Services and General Government hearing titled "Fiscal Year 2025 Request for...
CVS is under pressure and considering a breakup. Here’s why that...
A sign outside of a CVS pharmacy store on February 07, 2024 in Miami, Florida. Joe Raedle | Getty ImagesIt's time for a wellness...
FDA approves Bristol Myers Squibb’s schizophrenia drug, the first new type...
Bristol Myers Squibb's Cobenfy drugCourtesy: Bristol Myers SquibbThe Food and Drug Administration on Thursday approved Bristol Myers Squibb's highly anticipated schizophrenia drug Cobenfy,...
Novo Nordisk’s diabetes drug Ozempic may lower the risk of opioid...
A box of Ozempic made by Novo Nordisk is seen at a pharmacy in London, Britain March 8, 2024.Hollie Adams | ReutersNovo Nordisk's...
Novo Nordisk CEO to testify at Senate hearing over high weight...
Lars Fruergaard Jørgensen, CEO of Novo Nordisk, speaks during an interview in New York on Aug. 10, 2022.Christopher Goodney | Bloomberg | Getty...
